Eurobio

Executive Summary

Eurobio Scientific is a French in-vitro diagnostics (IVD) company specializing in infectious disease testing, immunology, and molecular biology. Founded in 1997 and headquartered in Les Ulis, France, Eurobio develops, manufactures, and distributes diagnostic tests and life science reagents. The company differentiates itself through a strong focus on internal manufacturing and high-end client service, positioning as a key player in the IVD market. Its expertise in transplantation (HLA) and infectious diseases aligns with growing demand for precision diagnostics. Eurobio's growth strategy centers on expanding its proprietary test menu and reinforcing its distribution network in Europe. As a private company, it has flexibility to invest in R&D and strategic acquisitions. While facing competition from global players like bioMérieux and Roche, Eurobio's niche focus on specialized assays and customer-centric support may drive steady revenue growth. Continued innovation and potential partnerships could enhance its market share in the evolving IVD landscape.

Upcoming Catalysts (preview)

• Q3 2026Launch of a novel multiplex respiratory panel70% success
• Q2 2026Expansion of manufacturing capacity for flagship tests80% success
• Q4 2026Strategic partnership for distribution in Southern Europe50% success